IMRICOR MEDICAL SYSTEMS CDI
Imricor Medical Systems Advances US Strategy with Pediatric Label Expansion Submission
Imricor submits pediatric NorthStar label via 510(k) to FDA, targeting 250 US children's hospitals; clearance expected this quarter to drive US growth.
Imricor to equip Semmelweis University with iCMR system for advanced cardiac imaging
Imricor Medical Systems (ASX: IMR) has been awarded a public tender by Semmelweis University in Hungary for the procurement of an iCMR (interventional cardiac magnetic resonance) electrophysiology system. Imricor is the world’s only manufacturer of the system and Semmelweis is the first medical school in the country to place such an order. The equipment will […]
Imricor Medical Systems receives key European certification for Vision-MR diagnostic catheter
Medical device manufacturer Imricor Medical Systems (ASX: IMR) has received CE mark certification to sell its low-cost Vision-MR diagnostic cardiac catheter in Europe. It is the first Imricor device to be approved under the European Union’s strict new medical device regulations regime. The Vision-MR diagnostic catheter is designed to work under real-time magnetic resonance imaging […]